Catherine Wood's EXAS Position Overview
Catherine Wood (via Ark Investment Management LLC) currently holds 2.2M shares of Exact Sciences Corporation (EXAS) worth $119.61 M, representing 0.71% of the portfolio. First purchased in 2020-Q3, this long-term strategic position has been held for 21 quarters.
Based on 13F filings, Catherine Wood has maintained a strategic position in EXAS, demonstrating sustained confidence in this investment. Largest addition occurred in Q4 2020, adding 4.8M shares. Largest reduction occurred in Q1 2023, reducing 4.7M shares.
Analysis based on 13F filings available since 2013 Q2
Catherine Wood's Exact Sciences Corporation (EXAS) Holding Value Over Time
Track share changes against reported price movement
Quarterly Exact Sciences Corporation (EXAS) Trades by Catherine Wood
| Period | Bought/Sold (Sh.) | % Change | Qtr. End Shares | Reported Price |
|---|---|---|---|---|
| Q3 2020 | +529,196 | New Buy | 529,196 | $101.95 |
| Q4 2020 | +4.78 M | Add 903.87% | 5.31 M | $132.49 |
| Q1 2021 | +3.84 M | Add 72.21% | 9.15 M | $131.78 |
| Q2 2021 | +1.58 M | Add 17.25% | 10.73 M | $124.31 |
| Q3 2021 | +1 M | Add 9.34% | 11.73 M | $95.45 |
| Q4 2021 | +1.77 M | Add 15.07% | 13.5 M | $77.83 |
| Q1 2022 | +827,948 | Add 6.13% | 14.32 M | $69.92 |
| Q2 2022 | +647,803 | Add 4.52% | 14.97 M | $49.81 |
| Q3 2022 | +2.59 M | Add 17.30% | 17.56 M | $32.49 |
| Q4 2022 | -1.52 M | Reduce 8.66% | 16.04 M | $49.51 |
| Q1 2023 | -4.66 M | Reduce 29.06% | 11.38 M | $67.81 |
| Q2 2023 | -4.22 M | Reduce 37.12% | 7.16 M | $93.90 |
| Q3 2023 | -874,167 | Reduce 12.22% | 6.28 M | $68.22 |
| Q4 2023 | -248,038 | Reduce 3.95% | 6.03 M | $73.98 |
| Q1 2024 | -2.77 M | Reduce 45.84% | 3.27 M | $69.06 |
| Q2 2024 | -2.92 M | Reduce 89.46% | 344,487 | $42.25 |
| Q3 2024 | -117,043 | Reduce 33.98% | 227,444 | $68.12 |
| Q4 2024 | -147,385 | Reduce 64.80% | 80,059 | $56.19 |
| Q1 2025 | -80,023 | Reduce 99.96% | 36 | $43.28 |
| Q3 2025 | +2.19 M | Add 6072589.00% | 2.19 M | $54.71 |
Catherine Wood's Exact Sciences Corporation Investment FAQs
Catherine Wood first purchased Exact Sciences Corporation (EXAS) in Q3 2020, acquiring 529,196 shares, as reported in their 13F filing for that period. Note: Analysis reflects filings available since Q2 2013; earlier records may be incomplete.
Catherine Wood has held Exact Sciences Corporation (EXAS) for 21 quarters since Q3 2020. Note: Analysis reflects filings available since Q2 2013; earlier records may be incomplete.
Catherine Wood's largest addition to Exact Sciences Corporation (EXAS) was in Q4 2020, adding 5,312,466 shares worth $703.85 M. Note: Analysis reflects filings available since Q2 2013; earlier records may be incomplete.
According to the latest 13F filing for Q3 2025, Catherine Wood's firm, Ark Investment Management LLC, owns 2,186,168 shares of Exact Sciences Corporation (EXAS), valued at approximately $119.61 M. Note: Analysis reflects filings available since Q2 2013; earlier records may be incomplete.
As of the Q3 2025 filing, Exact Sciences Corporation (EXAS) represents approximately 0.71% of Catherine Wood's publicly disclosed stock portfolio, making it one of their key holdings. Note: Analysis reflects filings available since Q2 2013; earlier records may be incomplete.
Catherine Wood's peak holding in Exact Sciences Corporation (EXAS) was 17,561,702 shares, as reported at the end of Q3 2022. Note: Analysis reflects filings available since Q2 2013; earlier records may be incomplete.